Learn More
Medchemexpress LLC Recilisib (ON 01210) | 334969-03-8 | MFCD07366276 | 99.9% | 336.79 g/mol | C16H13ClO4S | 25 MG

Supplier: Medchemexpress LLC HY10162525MG
Recilisib is a small-molecule radioprotectant that activates PI3K and AKT signaling to protect hematopoietic progenitor cells from radiation-induced damage. It preserves colony-forming ability of bone marrow cells in vitro and enhances recovery of myeloid progenitors in vivo. Chemical properties include formula C16H13ClO4S and molecular weight 336.79 g/mol.
- Acts as a radioprotectant by activating PI3K and AKT signaling in cells.
- Protects bone marrow colony-forming units from radiation-induced depletion.
- Enhances recovery and differentiation of primitive myeloid progenitors in vivo.
- Solid, white to off-white form with DMSO solubility and established in vivo formulations.
- High purity (≈99.9%) suitable for research use.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.